Behind the Batch Episode 2 – Giuliana Vallanti

Behind the Batch spotlights the moments that shape the people pioneering cell and gene therapy. Failed batches, first viable runs, tech transfers, and everything in between. In episode 2, our host Alex Shephard chats with Giuliana Vallanti, SVP Operations and R&D at AGC Biologics. She discusses two decades in cell and gene therapy, from process development at MolMed to leading operations and R&D at AGC Biologics in Milan, covering tech transfer from both sides of the CDMO relationship, the scale-up of lentiviral vector manufacturing, and how to judge which innovations actually deliver value.